Clinical Trial Update: Omegaven in Patients With Rheumatoid Arthritis (ORA-Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial ORA-Trial evaluating Omegaven in rheumatoid arthritis has completed; the snippet does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Humanis Klinikum Niederosterreich | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED